A case study on how DelveInsight supported the client by creating a focused conference coverage plan to gain an in-depth assessment of the oncology assets, their product developmental activities, and key milestones.
New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) — Oncology Conference Coverage — Stay Ahead in the Oncology Domain with Real-time Coverage from AACR, ESMO, ASCO, ASH, EHA, and Others | DelveInsight
A case study on how DelveInsight supported the client by creating a focused conference coverage plan to gain an in-depth assessment of the oncology assets, their product developmental activities, and key milestones.
DelveInsight, a leading healthcare competitive intelligence and consulting solutions company, released its new case study on Oncology Conference Coverage. A renowned pharma company wanted to assist them with congress coverage for key assets in the oncology field presented at various oncology conferences through thorough pre-conference planning, efficient intelligence collection during the event, and detailed post-conference reports.
The client requested the team to provide coverage of key events from major oncology conferences such as ASCO, ESMO, AACR, ASH, EHA, ASTRO, SOHO, and SITC, among others. The goal was to gather comprehensive insights on clinical trial updates, real-world trends, biomarker targets, shifts in treatment patterns for both hot and cold tumors, potential class failures, discoveries, advancements, industry trends, and expert opinions from KOLs.
DelveInsight’s CI team provided comprehensive coverage of all conferences and annual meetings throughout the year, following a pre-scheduled plan with a detailed calendar. This included extensive oncology conference coverage, along with insights delivered through newsletters, in-depth market research reports, and briefing presentations.
Connect with our oncology subject matter expert to understand how to leverage Oncology Conference Solutions for maximum benefit.
Oncology conferences are pivotal events that bring together experts, researchers, and clinicians from across the globe, offering a unique platform to exchange groundbreaking knowledge and the latest advancements in cancer treatments. These conferences provide invaluable insights into cutting-edge research, innovative therapies, and emerging technologies, from immunotherapy and personalized medicine to oncolytic virus therapy and novel drug delivery systems.
DelveInsight’s Oncology Conference Coverage Services offer a thorough analysis of outcomes from major events like AACR, ASCO, ESMO, ASH, ASTRO, SOHO, SITC, the European CAR T-cell Meeting, and IASLC. This detailed examination provides businesses with essential insights for competitive intelligence and market trend forecasting, supporting the formulation of future strategies.
Some of the key events DelveInsight will be covering in 2025 are below:
American Association for Cancer Research (AACR): The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other healthcare professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. This year the AACR Annual Meeting will take place at the McCormick Place Convention Center, Chicago, IL, from April 25-30, 2025.
Connect with DelveInsight to discover how our oncology analysts can provide Exclusive AACR Annual Meeting Program 2025 Event Coverage for You
American Society of Clinical Oncology (ASCO): The ASCO Annual Meeting is the premier global event for oncology professionals to network, collaborate, and inspire one another. Renowned for driving progress in the field, this unmissable gathering brings together top experts to shape the future of cancer care in a truly unique experience. The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting will take place May 30–June 3, 2025, at McCormick Place in Chicago, Illinois. The meeting will also be available online.
European Society for Medical Oncology (ESMO): The ESMO Congress is a leading international oncology forum that brings together clinicians, researchers, patient advocates, journalists, and healthcare industry professionals from around the globe. The 2025 European Society for Medical Oncology (ESMO) congresses will take place on the following dates:
ESMO Congress: October 17–21, 2025 in Berlin, Germany
ESMO Gynaecological Cancers Congress: June 19–21, 2025 in Vienna, Austria
American Society of Hematology (ASH): The American Society of Hematology (ASH) Annual Meeting & Exposition is the world’s premier event in hematology, bringing together researchers, clinicians, and industry leaders to discuss the latest advancements in blood disorders, including leukemia, lymphoma, and coagulation disorders. The conference features cutting-edge research presentations, clinical trial updates, and networking opportunities, shaping the future of hematologic care and therapies. The 67th ASH Annual Meeting and Exposition will take place from December 6–9, 2025 in Orlando, Florida. The conference will be held at the Orange County Convention Center.
DelveInsight’s Oncology Conference Coverage Solutions helped the client by:
- Offering comprehensive medical conference support, including conference planning/playbook, pre-conference assessments, daily updates, post-conference summaries, and a detailed final report.
- By prioritizing abstracts as with the vast amount of data available, it is crucial to select the most relevant and high-priority abstracts to ensure impactful insights and decisions.
- Concentrating on abstracts that address critical patient needs in areas like cancer screening, early-stage cancer treatment, and mutation/protein detection to inform accurate treatment decisions for relapsed or refractory patients.
- Providing data-driven insights from the analysis of Key Oral Abstract presentations, covering all relevant session formats such as Mini Oral, Industry Satellite Symposium, Proffered Paper Session, Educational Sessions, and EONS sessions.
- Sharing insights derived from interactions with presenters, oncologists, and researchers during industry-focused poster sessions.
- Offering detailed data on pivotal clinical trials, Late Breaking Abstracts (LBAs), and efficacy results for first-in-class therapies targeting new mutations, as well as key company collaborations happening on-site.
- Conducting thorough analyses of the latest clinical trial updates, treatment breakthroughs, and shifts in treatment strategies influenced by new data and evolving practices.
- Collecting and analyzing insights from various KOLs to answer Key Investigative Questions (KIQs), ensuring important perspectives are captured and used to drive actionable conclusions.
Get a proposal to find out how DelveInsight’s oncology congress coverage solutions can assist you
Pharma Competitive Intelligence Service tailored to Oncology Domain: The Oncology domain is one of our fortes, providing detailed insights into advancements across oncology such as multiple myeloma, NSCLC, CTCL, PTCL, Ewing sarcoma, PCPG, etc to name a few. Our services analyze competitors’ pipelines, clinical trial progress, gene and cell therapy innovations, and market entry strategies, as well as regulatory updates and patent landscapes specific to oncology. This intelligence enables stakeholders to identify emerging threats, uncover growth opportunities, and develop targeted strategies to remain competitive in this evolving therapeutic area.
Oncology Portfolio Management: DelveInsight’s deep expertise in oncology distinguishes us, as we excel in understanding the complexities of the cancer field. Our core focus is on aligning with strategic goals, analyzing advancements in the oncology sector, assessing the current demands of the oncology market, and providing exceptional client services.
Rare Oncology Indication Analysis: At DelveInsight, we are dedicated to providing essential reports that address the complexities of the rare cancer market. Our team of expert analysts diligently tracks the evolving developmental, regulatory, and commercial environments of competing products. We offer a range of services, including insightful conference evaluations and in-depth analyses of company progress and R&D activities, all designed to support the smooth development of oncology solutions tailored to our clients’ specific requirements.
Why Choose DelveInsight?
As a leader, you’re aware that conferences are crucial gatherings where company updates, industry conversations, and interactions with key opinion leaders come together, offering you essential firsthand and secondary competitive insights.
- Are you leveraging these conferences to gather vital competitive insights and maintain a leading edge?
- Would you like to gain an in-depth understanding of major developments, pipeline progress, and shifting views on key therapeutic strategies?
- Are you interested in learning what your competitors, key opinion leaders, and industry decision-makers are thinking to strategically inform your market approach?
By partnering with DelveInsight, you can take advantage of these conferences to stay informed about cutting-edge industry trends, emerging technologies, and market dynamics, enhancing your strategic decision-making. We specialize in thorough pre-conference planning, real-time intelligence gathering during the event, and comprehensive post-conference insights.
Ready to unlock the potential of your next conference? Schedule a call with our expert today!
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
CONTACT: Contact Us Shruti Thakur info@delveinsight.com +14699457679
- Goodfood Reports Second Quarter of 2025 Results with Net Sales of $31 million, Gross Profit of $13 million and Adjusted EBITDA¹ of $1 million - April 22, 2025
- Form 8.3 – [ALLIANCE PHARMA PLC – 17 04 2025] – (CGWL) - April 22, 2025
- [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 17 04 2025] – (CGWL) - April 22, 2025
